Second primary tumors in patients with thyroid cancer: data of the Italian Thyroid Cancer Observatory
Thyroid World Congress ePoster Library. Ramundo V. 06/22/19; 272147; 146
Valeria Ramundo
Valeria Ramundo
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

BACKGROUND: Epidemiological studies have shown an increase in incidence of second cancer after, as well as before, thyroid carcinoma. The relationship has been attributed to environmental risk factor, genetic susceptibility, a treatment effect, surveillance bias or prolonged survival.

METHODS: We analyzed data prospectively collected in The Italian Thyroid Cancer Observatory database over a 6-year period (from January 2013 to January 2019). Patients with thyroid cancer, diagnosed with a secondary primary tumor (other than thyroid cancer) were evaluated.

RESULTS: A total of 6317 patients were considered: 501 patients (7.9%) had at least two primary malignancies (459 patients had double primary malignancies, 42 patients, 0.7% had more than two primary malignancies; 341 [68%] females). The median age of diagnosis was 50 years for the second primary tumor and 57 years for thyroid cancer. Considering the second primary malignancy, 462 (85%) were solid and 84 (15%) were hematological. Among solid neoplasms, breast cancer was the most represented (31.6%), followed by melanoma (14.2%), colorectal (8.4%), kidney (5.6%), prostate (5.4%), other skin cancer (5.4%), lung cancer (3.4%), neuroendocrine tumor (2.8%), and others (23.2%). Among hematologic malignancies, lymphomas were 57%, leukemias 32%, multiple myelomas 2%, and others 9%.

DISCUSSION & CONCLUSION: Breast cancer is the most common tumor diagnosed in patients with thyroid cancer. The age of diagnosis of thyroid cancer seems not to be influenced by the presence of another malignancy. In contrast to other studies, the time between the two tumors is longer than one year, thus patients develop metachronous second primary tumor. 

 


BACKGROUND: Epidemiological studies have shown an increase in incidence of second cancer after, as well as before, thyroid carcinoma. The relationship has been attributed to environmental risk factor, genetic susceptibility, a treatment effect, surveillance bias or prolonged survival.

METHODS: We analyzed data prospectively collected in The Italian Thyroid Cancer Observatory database over a 6-year period (from January 2013 to January 2019). Patients with thyroid cancer, diagnosed with a secondary primary tumor (other than thyroid cancer) were evaluated.

RESULTS: A total of 6317 patients were considered: 501 patients (7.9%) had at least two primary malignancies (459 patients had double primary malignancies, 42 patients, 0.7% had more than two primary malignancies; 341 [68%] females). The median age of diagnosis was 50 years for the second primary tumor and 57 years for thyroid cancer. Considering the second primary malignancy, 462 (85%) were solid and 84 (15%) were hematological. Among solid neoplasms, breast cancer was the most represented (31.6%), followed by melanoma (14.2%), colorectal (8.4%), kidney (5.6%), prostate (5.4%), other skin cancer (5.4%), lung cancer (3.4%), neuroendocrine tumor (2.8%), and others (23.2%). Among hematologic malignancies, lymphomas were 57%, leukemias 32%, multiple myelomas 2%, and others 9%.

DISCUSSION & CONCLUSION: Breast cancer is the most common tumor diagnosed in patients with thyroid cancer. The age of diagnosis of thyroid cancer seems not to be influenced by the presence of another malignancy. In contrast to other studies, the time between the two tumors is longer than one year, thus patients develop metachronous second primary tumor. 

 


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings